PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.86%
Revenue growth under 50% of TSM's 21.56%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-2.73%
Negative gross profit growth while TSM is at 34.40%. Joel Greenblatt would examine cost competitiveness or demand decline.
-8.56%
Negative EBIT growth while TSM is at 41.39%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-8.56%
Negative operating income growth while TSM is at 41.39%. Joel Greenblatt would press for urgent turnaround measures.
11.72%
Net income growth under 50% of TSM's 51.38%. Michael Burry would suspect the firm is falling well behind a key competitor.
13.33%
EPS growth under 50% of TSM's 51.75%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
11.36%
Diluted EPS growth under 50% of TSM's 51.75%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.33%
Share change of 0.33% while TSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.16%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.33%
Dividend reduction while TSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-46.66%
Negative OCF growth while TSM is at 20.37%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.02%
Negative FCF growth while TSM is at 5174.99%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
216.43%
Similar 10Y revenue/share CAGR to TSM's 232.41%. Walter Schloss might see both firms benefiting from the same long-term demand.
187.87%
5Y revenue/share CAGR above 1.5x TSM's 40.17%. David Dodd would look for consistent product or market expansions fueling outperformance.
116.94%
3Y revenue/share CAGR above 1.5x TSM's 12.52%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
911.25%
10Y OCF/share CAGR above 1.5x TSM's 209.98%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
186.18%
5Y OCF/share CAGR above 1.5x TSM's 55.35%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
69.97%
3Y OCF/share CAGR above 1.5x TSM's 12.14%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1678.73%
Net income/share CAGR above 1.5x TSM's 237.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
888.08%
5Y net income/share CAGR above 1.5x TSM's 32.40%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
344.99%
3Y net income/share CAGR above 1.5x TSM's 4.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
240.19%
10Y equity/share CAGR in line with TSM's 249.76%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
109.17%
5Y equity/share CAGR above 1.5x TSM's 65.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
88.86%
3Y equity/share CAGR above 1.5x TSM's 23.67%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
100.01%
5Y dividend/share CAGR at 50-75% of TSM's 166.67%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
52.81%
3Y dividend/share CAGR above 1.5x TSM's 33.33%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
33.51%
AR growth well above TSM's 25.22%. Michael Burry fears inflated revenue or higher default risk in the near future.
30.00%
We show growth while TSM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.02%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.38%
BV/share growth above 1.5x TSM's 2.13%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.55%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
4.13%
R&D dropping or stable vs. TSM's 12.05%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
8.86%
SG&A declining or stable vs. TSM's 28.34%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.